LOVELAND, Colo., March 1, 2011 /PRNewswire/ -- Heska Corporation (Nasdaq: HSKA ; "Heska"), a leading provider of advanced diagnostic and specialty products to veterinarians, today announced the addition of a lactate meter analyzer to its portfolio of in-clinic blood analyzers.
Among other features, the handheld portable analyzer is used to measure lactate, and is ideal for both in-clinic and field use. It provides a lactate assay solution to complement the VitalPath® and DRI-CHEM® Analyzers for complete blood analysis.
"Heska is pleased to announce another product collaboration with Roche," commented Michael McGinley, President and Chief Operating Officer of Heska. "This new lactate meter analyzer will complement Heska's full range of blood analyzers, and is another example of our commitment to innovation within the veterinary industry."
Heska Corporation (Nasdaq: HSKA ) sells advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings to its customers include diagnostic and monitoring instruments and supplies as well as single use, point-of-care tests, vaccines and pharmaceuticals. The company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians. For further information on Heska and its products, visit the company's website at www.heska.com .
This announcement contains forward-looking statements regarding Heska's future financial and operating results. These statements are base